Acquiring Company
HLB Innovation
Acquired Company
HLB Cell
South KoreaBiotechnologyHealth CareBiotechnologyHealth CareTherapeuticsDescription
HLB Innovation has acquired HLB Cell to strengthen its domestic capabilities in cell therapy. This acquisition emphasizes HLB Innovation's commitment to advancing healthcare solutions. By integrating HLB Cell, the company aims to enhance its research and development in regenerative medicine. The move is expected to significantly boost their operational capabilities in this field.
Quick answer
HLB Innovation is acquiring HLB Cell, announced September 9, 2026. HLB Innovation is based in South Korea.
- How much did HLB Innovation pay for HLB Cell?
- The deal value was not disclosed.
- What does HLB Innovation do?
- HLB Innovation is a publicly traded company in South Korea and a member of the HLB Group.
- Where are HLB Innovation and HLB Cell based?
- HLB Innovation is based in South Korea.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Aethlon Medical to merge with North Immunology (September 17, 2026)
- Aurinia completes acquisition of Kezar Life Sciences (August 29, 2026)
- BioCryst acquires Astria Therapeutics for drug access (August 29, 2026)
- Ambros Therapeutics to merge with Werewolf Therapeutics (August 21, 2026)
- BioMarin to acquire Alesta Therapeutics for $275 million, $275M (August 18, 2026)
- Lakefront Biotherapeutics acquires Ouro Medicines (August 10, 2026)
Who to call at HLB Innovation, and when
When HLB Innovation changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day HLB Innovation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HLB Innovation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HLB Innovation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HLB Innovation makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired HLB Cell?
HLB Cell was acquired by HLB Innovation, based in South Korea. The deal was reported on September 9, 2026. HLB Innovation is a publicly traded company in South Korea and a member of the HLB Group. HLB Innovation is privately held and operates in Biotechnology.
When did HLB Innovation acquire HLB Cell?
HLB Innovation's acquisition of HLB Cell was reported on September 9, 2026. HLB Innovation has acquired HLB Cell to strengthen its domestic capabilities in cell therapy. This acquisition emphasizes HLB Innovation's commitment to advancing healthcare solutions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does HLB Cell do?
HLB Cell specializes in cell therapy and regenerative medicine. The company is dedicated to advancing therapeutic options for various diseases. They are known for their research and development in cellular treatments. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.